What other stocks do shareholders of MOTIF BIO PLC/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MOTIF BIO PLC/S investors own include Sorrento Therapeutics (SRNE) , Allergan (AGN) , Ampliphi Biosciences (APHB) , Neurocrine Biosciences (NBIX) , Forward Pharma A/S (FWP) , Novartis (NVS) , SDX Energy (SDX) , Block (SQ) and Adaptimmune Therapeutics (ADAP) .

When did MOTIF BIO PLC/S IPO?

MOTIF BIO PLC/S (MTFB) raised $17 million in an initial public offering on Friday, November 18th 2016. The company issued 2,400,000 shares at a price of $6.98 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

NASDAQ:MTFB

MOTIF BIO PLC/S (MTFB) Stock Price, News & Analysis

→ Uncover this 2024 Hidden Gem (From Tips4Traders) (Ad)

Free MTFB Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.10
▼
$0.12
50-Day Range: $0.10
▼
$0.11
52-Week Range: $0.08
▼
$11.50

Volume: 867,698 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get MOTIF BIO PLC/S alerts:

Ad Priority Gold

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

About MOTIF BIO PLC/S Stock (NASDAQ:MTFB)

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Ad Priority Gold

Biden to Launch “FedNOW” [Move Your Money Now]

Get your free information kit NOW, before it's too late.

MTFB Stock News Headlines

April 12, 2024 | tmcnet.com

Rice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulation

February 3, 2024 | msn.com

Small-molecule A485 mobilizes white blood cells on demand

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

November 3, 2023 | finance.yahoo.com

ROBIT PLC’S FINANCIAL INFORMATION AND ANNUAL GENERAL MEETING IN 2024

August 9, 2023 | finance.yahoo.com

4GLOBAL plc's (LON:4GBL) Stock Is Going Strong: Have Financials A Role To Play?

August 2, 2023 | finance.yahoo.com

Is There An Opportunity With Stelrad Group PLC's (LON:SRAD) 44% Undervaluation?

June 13, 2023 | finance.yahoo.com

DAVA - Endava plc

May 25, 2023 | finance.yahoo.com

Lacklustre Performance Is Driving NIOX Group Plc's (LON:NIOX) Low P/S

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

April 27, 2023 | morningstar.com

Cushman & Wakefield PLC CWK Stock Quote

February 22, 2023 | finance.yahoo.com

Evli Plc: Financial Statements Bulletin January-December 2022

February 13, 2023 | marketwatch.com

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2029

February 13, 2023 | marketwatch.com

Luciferase Assay Kits Market Trends and Opportunities and Forecast to 2028 with Top Countries Data

February 10, 2023 | wsj.com

Accenture PLC Cl A

November 16, 2022 | finance.yahoo.com

Consti Plc's financial reporting and Annual General Meeting in 2023

October 20, 2022 | marketwatch.com

Immunoprotein Reagents and Assay Kits Market Research on Present State and Future Growth Prospects of Key Players, Forecast by 2022 To 2028

October 3, 2022 | fool.co.uk

Motif Bio

August 15, 2022 | finance.yahoo.com

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

July 23, 2022 | apnews.com

The Worldwide Hemoglobin A1c Analyzer Industry is Expected to Reach $627 Million by 2027 - ResearchAndMarkets.com

July 15, 2022 | yahoo.com

Manifold Bio's molecular 'barcodes' could break through pharma's in vivo bottleneck

See More Headlines

Receive MTFB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTIF BIO PLC/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:MTFB
CUSIP: N/A
CIK: 1674657
Web: www.motifbio.com
Phone: 212-210-6248
Fax: N/A
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Dr. Graham George Lumsden (Age 59)
CEO & Exec. Director
Mr. Jonathan E. Gold (Age 46)
CFO & Exec. Director
Dr. David B. Huang (Age 44)
Chief Medical Officer
Mr. Robert Dickey IV (Age 63)
Advisor
Laurie Doyle
Head of Investor Relations & Corp. Communications

Key Competitors

View All Competitors

MTFB Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of MOTIF BIO PLC/S own?: Based on aggregate information from My MarketBeat watchlists, some companies that other MOTIF BIO PLC/S investors own include Sorrento Therapeutics (SRNE), Allergan (AGN), Ampliphi Biosciences (APHB), Neurocrine Biosciences (NBIX), Forward Pharma A/S (FWP), Novartis (NVS), SDX Energy (SDX), Block (SQ) and Adaptimmune Therapeutics (ADAP).
When did MOTIF BIO PLC/S IPO?: MOTIF BIO PLC/S (MTFB) raised $17 million in an initial public offering on Friday, November 18th 2016. The company issued 2,400,000 shares at a price of $6.98 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

This page (NASDAQ:MTFB) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MOTIF BIO PLC/S (MTFB) Stock Price, News & Analysis

About MOTIF BIO PLC/S Stock (NASDAQ:MTFB)

MTFB Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MTFB Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info